Compound Oyster Peptide Capsule
NDC Package 85631-004-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Compound Oyster Peptide capsules is thisproductisuable for men.Long em use helpsnouish the kidneys antvila energyenhancephyskcal igoimprowve thequalty of sexual le,imprvemornimg erecions and hardnes,andeeve postcoita fatigue. This formulation utilizes a capsule delivery system. Marketed by Bispit Canada Ltd., this product is identified by NDC 85631-004.

Identification & Billing

NDC Package Code
85631-004-01
Package Description
60 CAPSULE in 1 BOTTLE / 1.2 g in 1 CAPSULE
Product Code
85631-004
11-Digit Billing Format
85631000401

Clinical Specifications

Proprietary Name
Compound Oyster Peptide
Non-Proprietary Name
Compound Oyster Peptide
Substance Name
Lycium Chinense Fruit; Asian Ginseng; Licorice; Polygonatum Sibiricum Whole; Phyllolobium Chinense Seed; Riboflavin; Zinc Lactate; Taurine; Thiamine; Cornus Officinalis Whole; Sea Cucumber, Unspecified; Dioscorea Cayenensis Tuber; White Mulberry; Oyster, Unspecified
Dosage Form
Capsule - A solid oral dosage form consisting of a shell and a filling. The shell is composed of a single sealed enclosure, or two halves that fit together and which are sometimes sealed with a band. Capsule shells may be made from gelatin, starch, or cellulose, or other suitable materials, may be soft or hard, and are filled with solid or liquid ingredients that can be poured or squeezed.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Thisproductisuable for men.Long em use helpsnouish the kidneys antvila energyenhancephyskcal igoimprowve thequalty of sexual le,imprvemornimg erecions and hardnes,andeeve postcoita fatigue. This product ispurely derived from botanical extracls, making it suitable for long-term use withno reported adverse side effects

Regulatory & Marketing

Labeler Name
Bispit Canada Ltd.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
08-03-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 85631-004-01 identifies a specific commercial package of 60 capsule in 1 bottle / 1.2 g in 1 capsule of Compound Oyster Peptide, a human over the counter drug labeled by Bispit Canada Ltd.. This capsule is formulated for oral use and contains lycium chinense fruit; asian ginseng; licorice; polygonatum sibiricum whole; phyllolobium chinense seed; riboflavin; zinc lactate; taurine; thiamine; cornus officinalis whole; sea cucumber, unspecified; dioscorea cayenensis tuber; white mulberry; oyster, unspecified as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bispit Canada Ltd. on August 03, 2025. The current certification is valid through December 31, 2026.

How is this Bispit Canada Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 85631000401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
85631-004-01
11-Digit CMS (5-4-2)
85631-0004-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.